Best Agrolife Q3 FY26: Revenue falls 26% YoY but loss narrows

Revenue DeclinePat NegativeEbitda Margin ExpansionResults View source PDF Explain this filing

BESTAGRO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.4%Reaction day

₹19.98

prior close

₹18.91

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.6%-7.9% vs market

Pesticides & Agrochemicals peers, median of 25sector+2.6%-7.9% vs sector

On the reaction day the stock moved 7.9 pts less than Nifty Microcap 250 and 7.9 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.4+2.6-7.9+2.6-7.9

Next day

-5.0+3.6-8.6+4.0-8.9

-5.4+3.1-8.5+2.1-7.5

-3.5+2.6-6.1+0.3-3.8

-4.3+1.1-5.3-0.8-3.5

-7.7+0.3-8.0-0.3-7.4

-7.8+1.6-9.4+0.1-8.0

15d

-22.6-3.9-18.7-6.4-16.2

-18.2-8.1-10.1-10.8-7.4

-17.7-3.1-14.6-9.5-8.2

-3.6+9.2-12.7+0.5-4.0

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Best Agrolife Q3 FY26 revenue fell 26% YoY to Rs 202.9 crore, hit by erratic rainfall, floods, and low pest incidence. EBITDA improved to a Rs 3.8 crore gain from a Rs 5.8 crore loss, with margin at 1.9%. Q3 loss narrowed to Rs 12.7 crore from Rs 24.2 crore. 9M FY26 revenue was Rs 1,101.1 crore with PAT at Rs 46.1 crore. OPEX cut 36% YoY in Q3, inventory reduced 24%. Two new patented products, BestMan and Fetagen, crossed 4 lakh treated acres each.

Likely market impact

Sharp revenue decline but cost cuts narrowed losses. Weak near-term outlook from weather; new patented products gaining traction.